2010
DOI: 10.2478/v10007-010-0020-0
|View full text |Cite
|
Sign up to set email alerts
|

Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation

Abstract: Meloxicam (MLX) is a potent non-steroidal anti-inflammatory drug (NSAID) belonging to the enolic acid class. It preferentially inhibits COX-2 and is therefore used for the treatment of rheumatoid arthritis, osteoarthritis, and other joint diseases (1). Although MLX is well tolerated orally compared to other NSAIDs, it is associated with ulcerogenicity, bellyache and indigestion. This makes administration of MLX unsuitable for patients with gastric ulcer (2). Oral MLX administration is also associated with drug… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(26 citation statements)
references
References 15 publications
0
26
0
Order By: Relevance
“…Limitations of the conventional drug solubilization strategies (Pace et al, 1999; Bachhav and Patravale, 2010) have led to exploration and invention of newer drug solublization techniques. Several colloidal and vesicular systems such as liposomes, microspheres, nanoparticles and microemulsions, have been studied for solubility enhancement and encapsulation of hydrophobic drugs.…”
Section: Strategies For Solubilization Of Hydrophobic Drugsmentioning
confidence: 99%
“…Limitations of the conventional drug solubilization strategies (Pace et al, 1999; Bachhav and Patravale, 2010) have led to exploration and invention of newer drug solublization techniques. Several colloidal and vesicular systems such as liposomes, microspheres, nanoparticles and microemulsions, have been studied for solubility enhancement and encapsulation of hydrophobic drugs.…”
Section: Strategies For Solubilization Of Hydrophobic Drugsmentioning
confidence: 99%
“…The increase in the diameter due to cream spreading was noted, which gives the spreadability of formulation. [2021]…”
Section: Methodsmentioning
confidence: 99%
“…The volume difference between the carrageenan and control paws was used to evaluate the inflammatory response. Paw volume was measured using water plethysmometer immediately and 1, 2, 3, 4 and 5 h after carrageenan injection [16] .…”
Section: Determination Of Drug Content Spreadability Ph and Viscosimentioning
confidence: 99%